NALOXONE.Presents a question-and-answer advisory on administering naloxone, the drug of choice for reversing respiratory depression caused by narcotic overdose. Dosage and administration; Availability; Contraindications.GeverLarryN.EBSCO_AspNursing
The injection uses a needle that goes into muscle, but you can also inject it into a vein or under the skin. It’s often given in the outer thigh muscle, through clothes if needed. Zimhi is an FDA-approved single-dose, prefilled syringe that has the correct dosage already loaded into...
Naloxone is commonly used in comatose patients as a therapeutic and diagnostic agent. The standard dosage regimen is to administer from 0.4 to 2.0 mg slowly, preferably intravenously. Intramuscular administration is an alternative parenteral route, but if the patient is hypotensive, naloxone may not ...
While this study was statistically underpowered to detect differences in naloxone administration in total cumulative dosage and clinical sequelae between patients with NPO and fentanyl only OD, this study provides important preliminary data on NPOs to inform clinicians and patients of the severity of ODs...
We describe a patient who developed severe respiratory dysfunction after fentanyl patch abuse via insufflation, naloxone administration and aspiration. After o... EJ Scharman,AF Pizon - 《Clinical Toxicology》 被引量: 2发表: 2014年 Extracorporeal membrane oxygenation for cardiopulmonary failure following...
Respiratory, Thoracic, and Mediastinal Disorders:dyspnea, respiratory depression, hypoxia Skin and Subcutaneous Tissue Disorders:nonspecific injection site reactions, sweating Vascular Disorders:hypertension, hypotension, hot flashes, or flushing See alsoPRECAUTIONSandDOSAGE AND ADMINISTRATION; Usage in Adults, ...
It must also be reported that naloxon, used as an endorfine antagonist after an overdosage of endorfino-mimetics, can produce acute withdrawal symptoms and produce risk therefore. The use of naloxon must be indicated carefully - overdosage of endorfino mimetics - and administration must be ...
controlled study using one of three dosage strengths of buprenorphine TTS in 445 patients with chronic pain the adverse effects were mild and typical of the opioid analgesics; they included nausea (17%), vomiting (9.3%), dizziness (6.8%), tiredness (5.6%), constipation (5.3%), and...
Usage and dosage: can only be given intravenously, and can not be used with alkaline solution (such as NaHCO2) using a channel. The initial intravenous infusion rate was 2 to 5ug / (kg.min) Quantity: 20ug / (kg.min) Matters needing attention: High dose can accelerate the respiration,...
A number of clinical studies have demonstrated that, compared with the sustained-release monotherapies of oxycodone, the sustained-release combination therapies of oxycodone and naloxone are equivalent in analgesic effects at the same dosage, but can significantly improve bowel function and reduce the in...